MedTrace Logo

Intensive Unimanual (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegia

NCT02918890 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2024-12-16

Study results available
· View outcomes & findings →

Summary

A randomized control trial examining the relationship between changes in hand function and brain plasticity following intensive therapy. Two treatment approaches are used: constraint-induced movement therapy (CIMT) or Hand-Arm Bimanual Intensive Therapy (HABIT). The protocols have been developed at TC Columbia University to be child friendly and draw upon our extensive experience with constraint-induced movement therapy in children with cerebral palsy. Our center has been providing interventions camps for children with cerebral palsy since 1998. The interventions are performed in a 15 day day-camp setting with several children and at least one interventionist per child. The aim of the intervention is to improve the use of the affected hand and quality of overall movement in a fun, social setting. PARTICIPATION IS FREE. Please check out our website for more information: http://www.tc.edu/centers/cit/

Conditions

  • Cerebral Palsy
  • Hemiplegia
  • Children

Interventions

OTHER

Constraint-induced Movement Therapy

OTHER

Hand-arm Bimanual Intensive Therapy

Sponsors & Collaborators

  • Burke Medical Research Institute

    collaborator OTHER

  • Teachers College, Columbia University

    lead OTHER

Principal Investigators

  • Andrew Gordon, Ph.D. · Teachers College, Columbia University

  • Kathleen Friel, Ph.D. · Burke Neurological Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02918890 on ClinicalTrials.gov